MICHELE SPIRKO: Open Payments
NPI 1558810804 · AMHERST, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$171 in 9 payments from 8 companies in 2025. Trend: 2023 $450 · 2024 $500 · 2025 $171
Food & beverage: $171
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 2 | $42 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Echosens North America, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: SUBLOCADE, M-M-R II, The Cologuard Plus Collection Kit, Ozempic, AIRSUPRA, Fibroscan, UBRELVY, Auvelity.
Industry payments across MA — which companies pay providers there.
